Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




Clinical Trials

News from SCRIP

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

Tuesday, June 11, 2019 - 12:00pm

Condition:   Hepatitis B, Chronic
Interventions:   Drug: JNJ-73763989;   Drug: Placebo for JNJ-73763989;   Drug: JNJ-56136379;   Drug: Placebo for JNJ-56136379;   Drug: Nucleos(t)ide Analog (NA)
Sponsor:   Janssen Sciences Ireland UC
Not yet recruiting
read more

Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative Colitis

Monday, June 10, 2019 - 12:00pm

Condition:   Ulcerative Colitis
Interventions:   Dietary Supplement: Group 1- Control Diet;   Dietary Supplement: Group 2- UCD Diet
Sponsor:   Prof. Arie Levine
Not yet recruiting
read more

Feasibility Study of a Novel Single Use Robotic Colonoscopy System

Friday, June 7, 2019 - 12:00pm

Conditions:   Colonic Polyp;   Colon Adenoma;   Colorectal Cancer
Intervention:   Device: NISInspire-C System
Sponsors:   Bio-Medical Engineering (HK) Limited;   The University of Hong Kong
Recruiting
read more

Pages

Cardiovascular

Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

Monday, June 17, 2019 - 12:00pm

Conditions:   Venous Thromboembolism;   Dyslipidemias
Interventions:   Drug: Rosuvastatin 20mg;   Drug: Control
Sponsor:   Yonsei University
Recruiting
read more

EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

Monday, June 17, 2019 - 12:00pm

Conditions:   Atrial Fibrillation;   Coronary Heart Disease;   Cardiovascular Diseases;   Heart Failure;   Hypertension;   Peripheral Arterial Disease;   Stroke, Ischemic;   Asthma;   Chronic Obstructive Pulmonary Disease;   Obesity;   Cancer;   Chronic Kidney Diseases;   Diabetes Mellitus;   Dementia;   Depression;   Epilepsy;   Mental Health Disorder;   Rheumatoid Arthritis;   Blood Pressure
Intervention:  
Sponsor:   Future Genetics Limited
Not yet recruiting
read more

Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Valsartan in HFpEF Patients With Acute Decompensated Heart Failure (ADHF) Who Have Been Stabilized During Hospitalization (PARAGLIDE-HF)

Monday, June 17, 2019 - 12:00pm

Condition:   Heart Failure With Preserved Ejection Fraction (HFpEF)
Interventions:   Drug: sacubitril/valsartan;   Drug: valsartan
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting
read more

Pages

Publication Date: 
Friday, July 15, 2016 - 1:45pm
Category: 
Friday, July 15, 2016 - 1:45pm